Harvoni

China approves Descovy, Harvoni, Hemlibra
China approves Descovy, Harvoni, Hemlibra
BioCentury
China
Harvoni
Descovy
Hemlibra
Roche
Gilead Sciences
Flag link:
Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C
Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C
CP Wire
Gilead Sciences
generics
Epclusa
Harvoni
hepatitis C
Asegua Therapeutics
Flag link:
Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C
Gilead
Epclusa
Harvoni
Flag link:
Gilead wins reprieve in Merck's $2.5B patent lawsuit
Gilead wins reprieve in Merck's $2.5B patent lawsuit
Biopharma Dive
Gilead Sciences
Merck
patents
Sovaldi
Harvoni
hepatitis C
Idenix
Flag link:
Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict
Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict
Reuters
Gilead Sciences
hepatitis C
patents
Merck
Sovaldi
Harvoni
Flag link:
Dogged by AbbVie's new share-stealing Mavyret, Gilead's hep C forecast comes in far short
Dogged by AbbVie's new share-stealing Mavyret, Gilead's hep C forecast comes in far short
Fierce Pharma
AbbVie
Mavyret
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Flag link:
The 1 Thing Missing From Gilead Sciences' 2018 Priority List
The 1 Thing Missing From Gilead Sciences' 2018 Priority List
Motley Fool
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Epclusa
Flag link:
How can new launches mimic Keytruda, Harvoni, and Opdivo? A new report has some ideas
How can new launches mimic Keytruda, Harvoni, and Opdivo? A new report has some ideas
Fierce Pharma
drug launches
Keytruda
Harvoni
Opdivo
Merck
Bristol-Myers Squibb
Gilead Sciences
Flag link:
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
Investors Business Daily
AbbVie
Gilead Sciences
hepatitis C
Vosevi
Harvoni
Sovaldi
Epclusa
Viekira Pak
Flag link:
When It Comes To Abusive Drug Pricing, Don't Confuse Shkreli With Hep C Drugs
When It Comes To Abusive Drug Pricing, Don't Confuse Shkreli With Hep C Drugs
Forbes
drug pricing
hepatitis C
Martin Shkreli
Gilead Sciences
Harvoni
Sovaldi
Flag link:
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
Flag link:
Gilead works on lifecycle management for Sovaldi as Hep C franchise wanes
Gilead works on lifecycle management for Sovaldi as Hep C franchise wanes
BioPharma Dive
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Flag link:
Gilead Hep C Drugs Get Supplemental FDA Nod
Gilead Hep C Drugs Get Supplemental FDA Nod
Investopedia
Gilead Sciences
hepatitis C
FDA
Harvoni
Sovaldi
Flag link:
Gilead's Harvoni ads go from before to after with new creative focused on hep C cure
Gilead's Harvoni ads go from before to after with new creative focused on hep C cure
Fierce Pharma
Gilead Sciences
Harvoni
drug ads
DTC ads
hepatitis C
Flag link:
Gilead pushes hep C testing in baby boomers as its blockbusters plummet
Gilead pushes hep C testing in baby boomers as its blockbusters plummet
Fierce Pharma
Gilead Sciences
hepatitis C
baby boomers
DTC advertising
Harvoni
Sovaldi
Flag link:
Gilead cured hepatitis C. That’s become its biggest problem
Gilead cured hepatitis C. That’s become its biggest problem
Marketwatch
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Flag link:
Gilead’s Biggest Blockbusters Are Fading Fast, Biotech Warns
Gilead’s Biggest Blockbusters Are Fading Fast, Biotech Warns
Bloomberg
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Flag link:
Has Gilead Sciences' Cash Cow Finally Hit Bottom?
Has Gilead Sciences' Cash Cow Finally Hit Bottom?
Motley Fool
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Flag link:
The Most Expensive Drugs of 2016
The Most Expensive Drugs of 2016
Motley Fool
drug pricing
Gilead Sciences
Harvoni
Sovaldi
H.P. Acthar
Mallinckrodt
Shire
Cinryze
Daklinza
Bristol-Myers Squibb
Flag link:
Gilead’s Patent Loss to Merck Started With a Broken Friendship
Gilead’s Patent Loss to Merck Started With a Broken Friendship
Bloomberg
Gilead Sciences
Merck
patents
hepatitis C
Sovaldi
Harvoni
Flag link:

Pages